IDEAS home Printed from https://ideas.repec.org/a/spr/stabio/v17y2025i2d10.1007_s12561-024-09430-z.html
   My bibliography  Save this article

The Bayesian Group-Sequential Predictive Evidence Value Design for Phase II Clinical Trials with Binary Endpoints

Author

Listed:
  • Riko Kelter

    (University of Siegen)

  • Alexander Schnurr

    (University of Siegen)

Abstract

In clinical research, the initial efficacy of a new agent is typically assessed in a phase IIA study. Bayesian group-sequential designs are often based on predictive probability of trial success. In this paper, the novel Bayesian group-sequential predictive evidence value design is introduced, and we prove that the predictive probability approach is a special case of it. A comparison with Simon’s two-stage and competing Bayesian designs based on phase IIA cancer trials is provided. Results show that the novel design can improve operating characteristics such as the false-positive rate, probability of early stopping for futility and expected sample size of the trial. Given these advantages, the predictive evidence value design constitutes an important addition to the biostatistician’s toolbelt when planning a phase IIA trial the Bayesian way, in particular, when small sample sizes and a large probability for early termination under the null hypothesis are desired.

Suggested Citation

  • Riko Kelter & Alexander Schnurr, 2025. "The Bayesian Group-Sequential Predictive Evidence Value Design for Phase II Clinical Trials with Binary Endpoints," Statistics in Biosciences, Springer;International Chinese Statistical Association, vol. 17(2), pages 442-478, July.
    • Handle: RePEc:spr:stabio:v:17:y:2025:i:2:d:10.1007_s12561-024-09430-z
    DOI: 10.1007/s12561-024-09430-z
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s12561-024-09430-z
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1007/s12561-024-09430-z?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:stabio:v:17:y:2025:i:2:d:10.1007_s12561-024-09430-z. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.